The man known as the “Pharma Bro” and legally barred from the industry is seemingly back in the business.
In an interview with The Milk Road, a crypto newsletter, Shkreli said his idea isn’t just that would it replace expensive software, but also the computational power. The crypto element is his idea that people would be rewarded to share their computer power. “It’s a niche product for sure, but it could change the way medicine is made and help democratize this kind of fiefdom that’s the Pfizers, Mercks and Johnson & Johnson’s,” he said.
Shkreli also defended his price hike of Daraprim from $13.50 to $750 per pill. “The average cancer drug or rare disease drug in America in anywhere between $100,000 and $1 million. So I raised the price of Daraprim to something below, even though it’s a rare disease drug.” He differentiated his price rise from that of EpiPen.
“The companies that raised EpiPen’s price were Mylan and Pfizer, two really big companies. I ran a small, 100-person company in New York that we needed every dollar of revenue we can get.”
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »